|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,690.00 JPY | +0.51% |
|
+0.03% | +4.42% |
| 06-02 | TriVista Capital CEO: Long on Santen Pharmaceutical | MT |
| 05-13 | Santen Pharmaceutical Co Ltd - To Buy Back Up To 5.8% Of Own Shares Worth 35 Billion Yen | RE |
| Capitalization | 577B 3.96B 3.43B 3.23B 2.94B 5.43B 343B 6.12B 38.27B 14.65B 157B 14.84B 14.53B | P/E ratio 2025 |
13.6x | P/E ratio 2026 * | 16.6x |
|---|---|---|---|---|---|
| Enterprise value | 554B 3.8B 3.29B 3.1B 2.82B 5.22B 329B 5.88B 36.75B 14.06B 151B 14.25B 13.95B | EV / Sales 2025 |
1.61x | EV / Sales 2026 * | 1.79x |
| Free-Float |
94.58% | Yield 2025 |
2.54% | Yield 2026 * | 2.23% |
More valuation ratios
* Estimated data
More news
More recommendations
More press releases
| 1 day | +0.51% | ||
| 1 week | +0.03% | ||
| Current month | +5.43% | ||
| 1 month | +10.93% | ||
| 3 months | +17.16% | ||
| 6 months | +9.42% | ||
| Current year | +4.42% |
| 1 week | 1,652.5 |  | 1,700.5 |
| 1 month | 1,554 | | 1,722 |
| Current year | 1,310.5 | | 1,722 |
| 1 year | 1,310.5 | | 1,878.5 |
| 3 years | 956 | | 1,878.5 |
| 5 years | 956 | | 2,216 |
| 10 years | 956 | | 2,234 |
| Manager | Title | Age | Since |
|---|---|---|---|
Takeshi Ito
CEO | Chief Executive Officer | 65 | 2022-08-31 |
Kazuo Koshiji
DFI | Director of Finance/CFO | - | - |
Mika Masunari
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Akira Kurokawa
CHM | Chairman | 72 | 2024-03-31 |
Ippei Kurihara
BRD | Director/Board Member | 44 | 2024-05-31 |
Noboru Kotani
BRD | Director/Board Member | 68 | 2022-06-23 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 1.22% | 28 M€ | -7.66% | - | |
| 0.56% | 0 M€ | -.--% | - | |
| 0.19% | 1,022 M€ | +18.61% | - | |
| 0.13% | 70 M€ | -1.07% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.51% | +0.03% | +5.43% | +69.17% | 3.96B | ||
| -2.84% | -6.91% | -13.71% | +156.52% | 685B | ||
| -0.62% | -4.65% | +0.70% | -13.42% | 360B | ||
| -0.10% | -3.02% | +8.75% | +29.16% | 327B | ||
| -2.58% | -7.83% | -51.84% | +25.00% | 326B | ||
| -0.27% | -3.86% | +2.57% | -13.95% | 255B | ||
| -0.34% | -2.34% | +0.96% | +20.36% | 228B | ||
| -1.52% | -5.41% | -16.68% | +2.61% | 217B | ||
| -0.29% | -3.24% | -39.52% | -10.19% | 199B | ||
| -0.10% | -2.00% | -6.11% | +21.36% | 156B | ||
| Average | -0.81% | -3.75% | -10.94% | +28.66% | 275.59B | |
| Weighted average by Cap. | -1.30% | -4.71% | -12.59% | +44.72% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 299B 2.05B 1.78B 1.67B 1.52B 2.81B 177B 3.17B 19.81B 7.58B 81.24B 7.68B 7.52B | 294B 2.02B 1.75B 1.65B 1.5B 2.77B 175B 3.12B 19.51B 7.47B 80.01B 7.57B 7.41B |
| Net income | 34.69B 238M 206M 194M 177M 327M 20.6B 368M 2.3B 881M 9.44B 892M 873M | 34.13B 234M 203M 191M 174M 321M 20.27B 362M 2.26B 866M 9.28B 878M 859M |
| Net Debt | -22.91B -157M -136M -128M -117M -216M -13.6B -243M -1.52B -582M -6.23B -589M -577M | -51.45B -353M -306M -288M -262M -485M -30.55B -546M -3.41B -1.31B -14B -1.32B -1.3B |
More financial data
* Estimated data
Employees
3,744
Sector
Pharmaceuticals
Calendar
06-23
- Annual General Meeting
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-06-20 | 1,690.00 ¥ | +0.51% | 2,033,900 |
| 25-06-19 | 1,681.50 ¥ | -0.21% | 865,000 |
| 25-06-18 | 1,685.00 ¥ | +1.20% | 1,388,100 |
| 25-06-17 | 1,665.00 ¥ | -0.45% | 1,307,400 |
| 25-06-16 | 1,672.50 ¥ | -1.01% | 1,064,900 |
Delayed Quote Japan Exchange, June 20, 2025 at 02:30 am
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
1,690.00JPY
Average target price
2,122.22JPY
Spread / Average Target
+25.58%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4536 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition